Register now for Fin24 Dashboard and get access to portfolios, watchlists, financial comparison tools, and a whole lot more to help you achieve your financial goals.

Data provided by McGregor BFA
All data is delayed
Loading...
Where am I? Home
 
Prices are delayed by 15min.
Join the Fin24.com conversation about JSE-listed stock by using every time you tweet.

Health stocks just the right tonic

Feb 16 2010 07:31 Letitia Watson

Related Articles

Adcock eyes new opportunities

Aspen Pharmacare stocks jump

Medi-Clinic keeps up the growth

Netcare a defensive pick

Netcare group to list in UK

Health stocks tipped to bloom

 

Top Stories

Gauteng road project costs rocket

May 25 2012 13:58

The costs of the first phase of the Gauteng Freeway Improvement Project have increased significantly to almost R90bn, according to a report.

Greek euro worries pressures rand

May 25 2012 19:13

Uncertainty over the future of the euro zone returned to push the rand down against the dollar.

Sizeable drop in petrol price expected

May 24 2012 17:31

The Reserve Bank will maintain current interest rates, and a considerable reduction in the local petrol price is anticipated, says governor Gill Marcus.

 
Share Share line Print

Cape Town - Because of their defensive nature, health-related companies have performed reasonably well during the economic downturn.

Abdul Davids, head of research at Kagiso Asset Management, says health companies are dependent on government decisions about the industry - which in turn can affect their valuations. There is currently no certainty as to when the national health insurance (NHI) system will realise and how it could affect companies.

In general, Medi-Clinic's market risk is lower, while Netcare, according to Davids, has better growth potential. Medi-Clinic is well diversified with its Swiss interests, in particular, that are doing well.

Netcare is also strong offshore because of its interests in the United Kingdom. This group's big balance-sheet debt is being discharged, which will improve revenue growth.

Davids reckons Netcare and Medi-Clinic are attractive at current levels.

Pharmaceutical groups with a strong focus on generic medicines like Cipla Medpro and Adcock will probably benefit from the NHI.

Among local companies Cipla has the best capacity to increase its production of generics, expanding its growth potential.

According to Davids, Cipla and Aspen's earnings-growth prospects indicate a possible doubling over the next two to three years.

He reckons that Cipla in particular has good potential from the perspective of dividends and capital growth.

- Fin24.com

For more business news in Afrikaans, got to Sake24.com.

 
 
Comment on this story
0 comments
Add your comment
Comment 0 characters remaining
Facebook's intrinsic value
May 23 2012 11:32

When it comes to judging a company’s worth, value investors like Warren Buffett look at intrinsic value. By that measure, Facebook’s shares are worth less than $10. A Reuters analyst breaks down the math. (Reuters)

NicolaaSmith

CIPPA equals automatic zero erosion in the constant item economy We do not have stable – as in fixed real value – money. The real value of money is generally accepted by the public at large to be stable – as in fixed – in low inflation economies, but this is not true. The be... Read their blog...

Recently updated
Podcasts
The Sishen saga

Legal expert Peter Leon on the increasingly complex legal wrangle over the Sishen Iron Ore mine. Time: 8:17 Listen Here...

Before you list

Is the clarion call of the JSE calling? Listen to Fin24’s expert panel discussion before you list your small business. Time: 17:29

Compare and Buy

Compare and apply for hundreds of financial products from many suppliers.

Credit cards Medical aid Current accounts Think Money

Money Clinic

Money Clinic Do you have a question about your finances? We'll get an expert opinion.
Click here...

Loading...